Email updates

Keep up to date with the latest news and content from BMC Medicine and BioMed Central.

Journal App

google play app store
Open Access Highly Accessed Forum

DSM-5: a collection of psychiatrist views on the changes, controversies, and future directions

Charles B Nemeroff1, Daniel Weinberger2, Michael Rutter3, Harriet L MacMillan4, Richard A Bryant5, Simon Wessely6, Dan J Stein7, Carmine M Pariante8, Florian Seemüller9, Michael Berk1011, Gin S Malhi1213, Martin Preisig14, Martin Brüne15 and Paul Lysaker1617

Author Affiliations

1 Department of Psychiatry and Behavioral Sciences, University of Miami, Leonard M. Miller School of Medicine, Miami, FL, USA

2 Departments of Psychiatry, Neurology, Neuroscience and The Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Lieber Institute for Brain Development, 855 North Wolfe Street, Baltimore, MD 21205, USA

3 MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Kings College London, De Crespigny Park, Denmark Hill, London, UK

4 Departments of Psychiatry and Behavioural Neurosciences, and Department of Pediatrics, Offord Centre for Child Studies, McMaster University, 1280 Main St. West, Hamilton, ON, Canada

5 School of Psychology, University of New South Wales, Sydney, NSW 2052, Australia

6 Department of Psychological Medicine, Institute of Psychiatry, King’s College London, Weston Education Centre, Cutcombe Road, London, UK

7 Department of Psychiatry & Mental Health, University of Cape Town and Groote Schuur Hospital, Observatory, J2, Anzio Rd, Cape Town 7925, South Africa

8 Department of Psychological Medicine, Institute of Psychiatry, Kings College London, Room 2-055, The James Black Centre, 125 Coldharbour Lane, London, UK

9 Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Nussbaumstr.7, Munich 80336, Germany

10 IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, Ryrie Street, Geelong, VIC 3220, Australia

11 Department of Psychiatry, Orygen Research Centre and the Florey Institute for Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3052, Australia

12 Discipline of Psychiatry, Sydney Medical School, University of Sydney, Sydney, Australia

13 CADE Clinic, Department of Psychiatry, Royal North Shore Hospital, Sydney, Australia

14 Department of Psychiatry, University Hospital of Lausanne, Site de Cery, Prilly 1008, Switzerland

15 Division of Cognitive Neuropsychiatry and Psychiatric Preventive Medicine, LWL University Hospital, Ruhr-University Bochum, Alexandrinenstraße 1, Bochum D-44791, Germany

16 Richard L Roudebush VA Medical Center, Indianapolis, IN, USA

17 Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA

For all author emails, please log on.

BMC Medicine 2013, 11:202  doi:10.1186/1741-7015-11-202


All correspondence should be made to the journal editorial office: bmcmedicineeditorial@biomedcentral.com

Published: 12 September 2013

Abstract

The recent release of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) by the American Psychiatric Association has led to much debate. For this forum article, we asked BMC Medicine Editorial Board members who are experts in the field of psychiatry to discuss their personal views on how the changes in DSM-5 might affect clinical practice in their specific areas of psychiatric medicine. This article discusses the influence the DSM-5 may have on the diagnosis and treatment of autism, trauma-related and stressor-related disorders, obsessive-compulsive and related disorders, mood disorders (including major depression and bipolar disorders), and schizophrenia spectrum disorders.

Keywords:
DSM-5; Psychiatry; Autism; PTSD; Mood disorders; Bipolar; Obsessive-compulsive disorders; Depression; Schizophrenia